Elan, Abbott End Ranbaxy Suit Over Generic TriCor
Elan Pharma International Ltd. and Abbott Laboratories on Friday ended a patent infringement suit in New Jersey over Ranbaxy Inc.'s plans to introduce a generic version of cholesterol drug TriCor....To view the full article, register now.
Already a subscriber? Click here to view full article